Summary
Symbiotec Pharmalab share holding pattern reports the following shareholding: Symbiotec Pharmalab Total Promoters is at 33.28%, Mutual Fund at 12.18%, Insurance at 1.07%, Foreign Institutional Investors at 3.79%, Domestic Institutional Investors at 19.52%, and Retail at 30.16%. This breakdown provides a quick snapshot of ownership distribution for Symbiotec Pharmalab share holding pattern in 2026-27.
Symbiotec Pharmalab FAQs
As of 11-2026, the promoter shareholding in Symbiotec Pharmalab stands at 33.28% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Symbiotec Pharmalab is 3.79% and 19.52% respectively.
The retail shareholding of the Symbiotec Pharmalab is 30.16%.
Changes in shareholding patterns of Symbiotec Pharmalab can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Symbiotec Pharmalab are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in SYMBIOTEC
